Animal & Plant Derived Vaccines

It has been about 30 years since the first plant engineering technology was established. Although the concept of plant-based pharmaceuticals or vaccines motivates us to develop practicable commercial products using plant engineering, there are some difficulties in reaching the final goal: to manufacture an approved product. At present, the only plant-made vaccine approved by the United States Department of Agriculture is a Newcastle disease vaccine for poultry that is produced in suspension-cultured tobacco cells. The progress toward commercialization of plant-based vaccines takes much effort and time, but several candidate vaccines for use in humans and animals are in clinical trials. This review discusses plant engineering technologies and regulations relevant to the development of plant-based vaccines and provides an overview of human and animal vaccines currently under clinical trials.

    Related Conference of Animal & Plant Derived Vaccines

    November 19-20, 2025

    6th International Conference on Vaccine Research

    Tokyo, Japan
    December 22-23, 2025

    7th World Congress on Vaccine and Immunology

    Amsterdam, Netherlands
    September 21-22, 2026

    44th Euro Global Summit and Expo on Vaccines & Vaccination

    Barcelona, Spain

    Animal & Plant Derived Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in